(MedPage Today) — A single intravenous infusion of adeno-associated virus serotype 9 encoding beta-galactosidase (AAV9-GLB1) was associated with short-lived adverse events, increased beta-galactosidase levels, and signs of delayed progression…
Source link : https://www.medpagetoday.com/neurology/generalneurology/119830
Author :
Publish date : 2026-02-10 21:58:00
Copyright for syndicated content belongs to the linked Source.
